Científicos trabajan en la lucha contra el COVID-19
Científicos trabajan en la lucha contra el COVID-19 PLAY VIDEO 06.20.2020
Aqualung Takes Genomic Approach to COVID-19’s Killer Lung Inflammation
Targets Protein Linked To Acute Respiratory Distress Syndrome Aqualung Takes Genomic Approach to COVID-19’s Killer Lung Inflammation Andrew McConaghieandrew.mcconaghie@informa.com Executive Summary Acute
COVID Patients in Intensive Care units – KGUN9 Interview
Dr. Joe GN Garcia talks with local news station KGUN-9 about the uptick in deaths with COVID-19, primarily in patients transferred to ICU.
Dr. Joe GN Garcia addresses the Foe Behind Covid-19 Deaths: Acute Respiratory Distress Syndrome in this interview with eHealth Radio Network
Joe GN Garcia addresses the Foe Behind Covid-19 Deaths: Acute Respiratory Distress Syndrome in this interview with eHealth
Why An Experimental Therapy for Inflammatory Disorders Could Help the Fight Against COVID-19
PLAY PRESS RELEASE 05.27.2020
Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension
Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension Jiwang Chen 1, Justin R Sysol 1, Sunit Singla 1, Shuangping Zhao 1, Aya Yamamura 1, Daniela Valdez-Jasso 1, Taimur
Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-a–mediated Apoptosis in Human Lung Endothelial Cells
Novel Mechanism for Nicotinamide Phosphoribosyltransferase Inhibition of TNF-α–mediated Apoptosis in Human Lung Endothelial Cells Radu C. Oita,1Sara M. Camp,1Wenli